Biosimulation Market by Product (Software and Services), by Application (Drug Development, Drug Discovery, and Others), and by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Regulatory Authorities, and Academic Research Institutions)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the biosimulation market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the biosimulation market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biosimulation market on a global level.

In order to give the users of this report a comprehensive view of the biosimulation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the biosimulation market based on product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into services and software. The services segment is further classified into contract services and in-house services. By application, the market includes drug discovery, drug development, and others. By end-user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, regulatory authorities, and academic research institutions. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global biosimulation market include Dassault Systèmes SE, Certara USA, Inc., Chemical Computing Group, Physiomics, In Silico Biosciences, INOSIM Software, Advanced Chemistry Development, Inc., Schrodinger, Inc., Genedata AG, and Rhenovia Pharma Ltd., among others.

This report segments the global biosimulation market as follows:

Global Biosimulation Market: Product Analysis

	Software
	Services 
	
		In-House Services
		Contract Services
	
	

Global Biosimulation Market: Application Analysis

	Drug Development
	Drug Discovery
	Others

Global Biosimulation Market: End-User Analysis

	Pharmaceutical and Biotechnology Companies
	Contract Research Organizations
	Regulatory Authorities
	Academic Research Institutions

Global Biosimulation Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa